86480624 - HAMPLATIN

Information

  • Trademark
  • 86480624
  • Serial Number
    86480624
  • Registration Number
    5171990
  • Filing Date
    December 15, 2014
    10 years ago
  • Registration Date
    March 28, 2017
    7 years ago
  • Transaction Date
    November 21, 2023
    a year ago
  • Status Date
    October 13, 2023
    a year ago
  • Published for Opposition Date
    June 07, 2016
    8 years ago
  • Location Date
    February 21, 2017
    7 years ago
  • First Use Anywhere Date
    May 10, 2016
    8 years ago
  • First Use In Commerce Date
    May 10, 2016
    8 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    PEREZ, STEVEN M
  • Attorney Docket Number
    ACIP0124
    Attorney Name
    Timothy T. Wang
    Law Office Assigned Location Code
    L10
  • Owners
Mark Drawing Code
5000
Mark Identification
HAMPLATIN
Case File Statements
  • DM0000: The mark consists of the term "HAMPLATIN" in stylized font.
  • GS0051: Tonics of medicines, namely, medicinal tea; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemico-pharmaceutical preparations for tumor-suppression and antiviral treatment; Injectable syringes sold filled with vaccines, antivirals and tumor-suppression agents; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctura in the nature of medicinal herb extracts; Tincture of iodine; Tinctures in the nature of antiseptics for use in the treatment of traumatic injuries; Herbs for medicinal purposes
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0421: Technical research and development in the fields of vaccines, medicines, dietary supplements and food; Technical Project studies in the nature of scientific research; Quality testing for medicines, dietary supplements, food and medicine intermediate; Chemical analysis; Chemical engineering; Working on and evaluation of chemical syntheses; Chemical research; Bacteriological research; Biological research; Conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Industrial design
Case File Event Statements
  • 10/13/2023 - a year ago
    30 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 3/28/2022 - 2 years ago
    29 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 3/28/2017 - 7 years ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/22/2017 - 7 years ago
    27 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 2/21/2017 - 7 years ago
    26 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 2/15/2017 - 7 years ago
    25 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 1/25/2017 - 8 years ago
    24 - USE AMENDMENT FILED Type: IUAF
  • 2/11/2017 - 7 years ago
    23 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/25/2017 - 8 years ago
    22 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 8/2/2016 - 8 years ago
    21 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/7/2016 - 8 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/7/2016 - 8 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/18/2016 - 8 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/29/2016 - 8 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/26/2016 - 8 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/25/2016 - 8 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/25/2016 - 8 years ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/27/2015 - 9 years ago
    13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/27/2015 - 9 years ago
    12 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/27/2015 - 9 years ago
    11 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/29/2015 - 9 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/28/2015 - 9 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/28/2015 - 9 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/28/2015 - 9 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/28/2015 - 9 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/28/2015 - 9 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/26/2015 - 9 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/4/2015 - 9 years ago
    3 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/19/2014 - 10 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/18/2014 - 10 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP